Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA7 | P43166 | 4/20 | 0.46 |
| ▸ | CA9 | Q16790 | 4/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | IKBKB | O14920 | 1/20 | 0.41 |
| ▸ | ESRRB | O95718 | 1/20 | 0.41 |
| ▸ | ESRRG | P62508 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28033110 | 0.84 | PPM1B (0.54) | ALDH1A1GFERMAPTKDM4EHPGD | |
| SCHEMBL440293 | 0.82 | ALDH1A1 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL562543 | 0.82 | IKBKB (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1805264 | 0.81 | CES2 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9256689 | 0.80 | HSD17B1 (0.46) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL9797011 | 0.80 | ALDH1A1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12583326 | 0.79 | CA12 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1329143 | 0.79 | CES2 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5369877 | 0.79 | CES2 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7409099 | 0.79 | MAPT (0.48) | ALDH1A1TSHRGFERMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119050430-B | Rare earth-vanadium redox flow battery | 湖南省银峰新能源有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119050430-A | Rare earth-vanadium redox flow battery | 湖南省银峰新能源有限公司 | 2024-11-29 | — | — | CN | claimed |
| EP-0048222-B1 | STABILISATION OF THERMOPLASTICS THAT CONTAIN CHLORINE WITH M-AMINO PHENOLS | CIBA-GEIGY AG (CH) | 1984-12-27 | — | — | EP | claimed |
| US-4385147-A | Stabilization of chlorine-containing thermoplastics with m-aminophenol derivatives | CIBA-GEIGY CORPORATION (US) | 1983-05-24 | — | — | US | claimed |
| EP-0048222-A1 | Stabilisation of thermoplastics that contain chlorine with m-amino phenols | CIBA-GEIGY AG (CH) | 1982-03-24 | — | — | EP | claimed |
| US-12459895-B2 | MEK inhibitors and uses thereof | Ikena Oncology, Inc. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-4532470-A1 | MEK INHIBITORS AND USES THEREOF | Ikena Oncology, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| CN-119768393-A | MEK inhibitors and uses thereof | 医肯纳肿瘤学公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119050430-B | Rare earth-vanadium redox flow battery | 湖南省银峰新能源有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119050430-B | Rare earth-vanadium redox flow battery | 湖南省银峰新能源有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119050430-A | Rare earth-vanadium redox flow battery | 湖南省银峰新能源有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-119050430-A | Rare earth-vanadium redox flow battery | 湖南省银峰新能源有限公司 | 2024-11-29 | — | — | CN | disclosed |
| EP-2401267-A1 | JAK KINASE MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF | Ambit Biosciences Corporation (US) | 2012-01-04 | — | — | EP | disclosed |
| US-8008481-B2 | Indazole compounds | ABBVIE INC. | 2011-08-30 | — | — | US | disclosed |
| US-20100317659-A1 | JAK KINASE MODULATING COMPOUNDS AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORP. | 2010-12-16 | — | — | US | disclosed |
| WO-2010099379-A1 | JAK KINASE MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORPORATION (US) | 2010-09-02 | — | — | WO | disclosed |
| US-20070282101-A1 | Indazole compounds | ABBVIE INC. | 2007-12-06 | — | — | US | disclosed |
| EP-0048222-B1 | STABILISATION OF THERMOPLASTICS THAT CONTAIN CHLORINE WITH M-AMINO PHENOLS | CIBA-GEIGY AG (CH) | 1984-12-27 | — | — | EP | disclosed |
| US-4385147-A | Stabilization of chlorine-containing thermoplastics with m-aminophenol derivatives | CIBA-GEIGY CORPORATION (US) | 1983-05-24 | — | — | US | disclosed |
| EP-0048222-A1 | Stabilisation of thermoplastics that contain chlorine with m-amino phenols | CIBA-GEIGY AG (CH) | 1982-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070282101-A1 | Indazole compounds | CYP3A43, CYP3A7, UGT1A1 | CA12 3232/4885CA1 3728/4885CA2 3954/4885 |
| US-12459895-B2 | MEK inhibitors and uses thereof | BRAF, NRAS, KRAS | CA12 4423/4885CA1 4614/4885CA2 4019/4885 |
| US-20100317659-A1 | JAK KINASE MODULATING COMPOUNDS AND METHODS OF USE THEREOF | JAK2, JAK3, JAK1 | CA12 4682/4885CA1 4854/4885CA2 4340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.